  The epigenome, i.e. the whole of chromatin modifications, is transferred from
mother to daughter cells during cell differentiation. When de novo chromatin
modifications (establishment or erasure of, respectively, new or pre-existing
DNA methylations and/or histone modifications) are made in a daughter cell,
however, it has a different epigenome than its mother cell. Although de novo
chromatin modifications are an important event that comprises elementary
processes of cell differentiation, its molecular mechanism remains poorly
understood. We argue in this Letter that a key to solving this problem lies in
understanding the role of long non-coding RNAs (lncRNAs)- a type of RNA that is
becoming increasingly prominent in epigenetic studies. Many studies show that
lncRNAs form ribonucleo-protein complexes in the nucleus and are involved in
chromatin modifications. However, chromatin-modifying enzymes lack the
information about genomic positions on which they act. It is known, on the
other hand, that a single-stranded RNA in general can bind to a double-stranded
DNA to form a triple helix. If each lncRNA forms a ribonucleo-protein complex
with chromatin-modifying enzymes on one hand and, at the same time, a triple
helix with a genomic region based on its specific nucleotide sequence on the
other hand, it can induce de novo chromatin modifications at specific sites.
Thus, the great variety of lncRNAs can be explained by the requirement for the
diversity of "genomic address codes" specific to their cognate genomic regions
where de novo chromatin modifications take place.
